{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:52:17Z","timestamp":1785894737522,"version":"3.56.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["202314-31"],"award-info":[{"award-number":["202314-31"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2024-157283OB-I00"],"award-info":[{"award-number":["PID2024-157283OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["GA N\\u00B0 101095426"],"award-info":[{"award-number":["GA N\\u00B0 101095426"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030917","name":"Computer Network Information Center, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"&apos;la Caixa&apos; Foundation","doi-asserted-by":"publisher","award":["LCF\/PR\/HR22\/52420011"],"award-info":[{"award-number":["LCF\/PR\/HR22\/52420011"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.atherosclerosis.2026.120718","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:32:08Z","timestamp":1779582728000},"page":"120718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hematopoietic somatic mutations in atherosclerotic cardiovascular disease"],"prefix":"10.1016","volume":"417","author":[{"given":"Beatriz L.","family":"Ramos-Neble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-629X","authenticated-orcid":false,"given":"Jos\u00e9 J.","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120718_bib1","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"8003","key":"10.1016\/j.atherosclerosis.2026.120718_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-024-07066-z","article-title":"Deciphering cell states and genealogies of human haematopoiesis","volume":"627","author":"Weng","year":"2024","journal-title":"Nature"},{"issue":"7913","key":"10.1016\/j.atherosclerosis.2026.120718_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","article-title":"Clonal dynamics of haematopoiesis across the human lifespan","volume":"606","author":"Mitchell","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s43587-024-00589-0","article-title":"Tissue mosaicism following stem cell aging: blood as an exemplar","volume":"4","author":"Kapadia","year":"2024","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2026.120718_bib6","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.2023022222","article-title":"Causes and consequences of clonal hematopoiesis","volume":"142","author":"Weeks","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-020-02114-w","article-title":"Mosaic loss of human Y chromosome: what, how and why","volume":"139","author":"Guo","year":"2020","journal-title":"Hum Genet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120718_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41576-024-00805-y","article-title":"The effects of loss of Y chromosome on male health","volume":"26","author":"Bruhn-Olszewska","year":"2025","journal-title":"Nat Rev Genet"},{"issue":"7831","key":"10.1016\/j.atherosclerosis.2026.120718_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120718_bib14","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1038\/s41591-024-03213-1","article-title":"Unidirectional association of clonal hematopoiesis with atherosclerosis development","volume":"30","author":"Diez-Diez","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI198861","article-title":"Detection of clonal hematopoiesis of indeterminate potential via genome or exome sequencing underestimates disease associations","author":"Corty","year":"2026","journal-title":"J Clin Investig"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2026.120718_bib9","first-page":"1590","article-title":"Clonal hematopoiesis: mechanisms driving dominance of stem cell clones","volume":"136","author":"Challen","year":"2020","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2026.120718_bib10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"7939","key":"10.1016\/j.atherosclerosis.2026.120718_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"issue":"7895","key":"10.1016\/j.atherosclerosis.2026.120718_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41586-021-04312-6","article-title":"Life histories of myeloproliferative neoplasms inferred from phylogenies","volume":"602","author":"Williams","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120718_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2026.120718_bib17","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120718_bib18","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120718_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41569-025-01148-9","article-title":"Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target","volume":"22","author":"Schuermans","year":"2025","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120718_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120718_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s44161-022-00206-6","article-title":"TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease","volume":"2","author":"Zekavat","year":"2023","journal-title":"Nat Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamacardio.2023.5095","article-title":"Somatic and germline variants and coronary heart disease in a Chinese population","volume":"9","author":"Zhao","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","article-title":"Clonal hematopoiesis is associated with higher risk of stroke","volume":"53","author":"Bhattacharya","year":"2022","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120718_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017915","article-title":"Impact of carrying DNMT3A or TET2 mutations on plaque characteristics and prognosis in patients with STEMI based on OCT","volume":"18","author":"Sun","year":"2025","journal-title":"Circ, Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.123.004415","article-title":"Invasive assessment of coronary artery disease in clonal hematopoiesis of indeterminate potential","volume":"17","author":"Heimlich","year":"2024","journal-title":"Circ Genom Precis Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurheartj\/ehaf602","article-title":"Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease","volume":"47","author":"von Scheidt","year":"2026","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.120718_bib27","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jacc.2023.03.401","article-title":"Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease","volume":"81","author":"Gumuser","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120718_bib28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.2022017661","article-title":"Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke","volume":"141","author":"Arends","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00392-022-02039-6","article-title":"Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors","volume":"112","author":"Jiang","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103964","article-title":"Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction","volume":"78","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120718_bib31","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/s41591-024-03188-z","article-title":"Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials","volume":"30","author":"Marston","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/eurheartj\/ehaa845","article-title":"Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations","volume":"42","author":"Assmus","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib34","article-title":"Clonal hematopoiesis and incident heart failure","author":"Flynn","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120718_bib35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamacardio.2025.3369","article-title":"Clonal hematopoiesis and risk of new-onset myocarditis and Pericarditis","volume":"10","author":"Schuermans","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120718_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/eurheartj\/ehad670","article-title":"Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias","volume":"45","author":"Schuermans","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120718_bib37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/eurheartj\/ehad869","article-title":"Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study","volume":"45","author":"Ahn","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171634","article-title":"Clonal hematopoiesis activates procalcific pathways in macrophages and promotes aortic valve stenosis","volume":"136","author":"Abplanalp","year":"2026","journal-title":"J Clin Investig"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120718_bib39","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehae052","article-title":"Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations","volume":"45","author":"Zuriaga","year":"2024","journal-title":"Eur Heart J"},{"issue":"45","key":"10.1016\/j.atherosclerosis.2026.120718_bib40","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1093\/eurheartj\/ehae682","article-title":"The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy","volume":"45","author":"Verdonschot","year":"2024","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2026.120718_bib41","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","article-title":"Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction","volume":"77","author":"Pascual-Figal","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120718_bib42","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/s41588-023-01555-z","article-title":"Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis","volume":"55","author":"Stacey","year":"2023","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120718_bib43","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","article-title":"Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/CIRCULATIONAHA.122.062126","article-title":"Interleukin-6 receptor polymorphism attenuates clonal hematopoiesis-mediated coronary artery disease risk among 451 180 individuals in the UK biobank","volume":"147","author":"Vlasschaert","year":"2023","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.120718_bib45","first-page":"2214","article-title":"A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets","volume":"141","author":"Vlasschaert","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120718_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","article-title":"PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy","volume":"23","author":"Hsu","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-Related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120718_bib48","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/s41588-025-02296-x","article-title":"Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis","volume":"57","author":"McLoughlin","year":"2025","journal-title":"Nat Genet"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2026.120718_bib49","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.2023020331","article-title":"PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy","volume":"142","author":"Miller","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120718_bib50","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.2025028417","article-title":"Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women","volume":"146","author":"Pershad","year":"2025","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120718_bib51","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","article-title":"Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking","volume":"34","author":"Dawoud","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib52","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1038\/s41598-022-09604-z","article-title":"Genetics of smoking and risk of clonal hematopoiesis","volume":"12","author":"Levin","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120718_bib53","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cell.2021.01.049","article-title":"Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis","volume":"184","author":"Heyde","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120718_bib54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-021-00554-z","article-title":"Clonal haematopoiesis and atherosclerosis: a chicken or egg question?","volume":"18","author":"Sanchez-Cabo","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib55","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1038\/s41467-024-52302-9","article-title":"Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis","volume":"15","author":"Uddin","year":"2024","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120718_bib70","first-page":"805","article-title":"Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes","volume":"2","author":"Rauch","year":"2023","journal-title":"Nat Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.200334","article-title":"Common clonal hematopoiesis driver mutations have disparate effects on macrophage cytokines, clonal expansion, and atherogenesis","volume":"11","author":"Carter","year":"2026","journal-title":"JCI Insight"},{"issue":"6327","key":"10.1016\/j.atherosclerosis.2026.120718_bib63","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120718_bib71","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s44161-023-00281-3","article-title":"Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis","volume":"2","author":"Liu","year":"2023","journal-title":"Nat Cardiovasc Res"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120718_bib66","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.123.065344","article-title":"BRCC3-Mediated NLRP3 deubiquitylation promotes inflammasome activation and atherosclerosis in Tet2 clonal hematopoiesis","volume":"148","author":"Yalcinkaya","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120718_bib84","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s44161-024-00579-w","article-title":"Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity","volume":"3","author":"Sato","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120718_bib83","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","article-title":"Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 (V617F) mice","volume":"123","author":"Wang","year":"2018","journal-title":"Circ Res"},{"issue":"7853","key":"10.1016\/j.atherosclerosis.2026.120718_bib80","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120718_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155724","article-title":"Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis","volume":"132","author":"Liu","year":"2022","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib81","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182939","article-title":"Inflammatory crosstalk impairs phagocytic receptors and aggravates atherosclerosis in clonal hematopoiesis in mice","volume":"135","author":"Liu","year":"2024","journal-title":"J Clin Investig"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120718_bib56","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2025.07.058","article-title":"Clonal hematopoiesis and cardiovascular outcomes in older women","volume":"86","author":"Ezzat","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120718_bib57","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fimmu.2019.00210","article-title":"TET enzymes and 5hmC in adaptive and innate immune systems","volume":"10","author":"Lio","year":"2019","journal-title":"Front Immunol"},{"issue":"35","key":"10.1016\/j.atherosclerosis.2026.120718_bib59","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1073\/pnas.1112317108","article-title":"Ten-eleven-translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice","volume":"108","author":"Ko","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120718_bib62","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108326","article-title":"TET2-Loss-of-Function-Driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity","volume":"33","author":"Fuster","year":"2020","journal-title":"Cell Rep"},{"issue":"7569","key":"10.1016\/j.atherosclerosis.2026.120718_bib65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature15252","article-title":"Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp Hematol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120718_bib68","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.immuni.2022.06.022","article-title":"DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages","volume":"55","author":"Cobo","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120718_bib69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120718_bib73","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","article-title":"Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis","volume":"3","author":"Cook","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120718_bib74","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","article-title":"TET2-Driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial","volume":"7","author":"Svensson","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"43","key":"10.1016\/j.atherosclerosis.2026.120718_bib75","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1093\/eurheartj\/ehae546","article-title":"Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis","volume":"45","author":"Zuriaga","year":"2024","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.120718_bib76","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jacc.2025.08.025","article-title":"Colchicine and longitudinal dynamics of clonal hematopoiesis: an exploratory substudy of the LoDoCo2 trial","volume":"86","author":"Mohammadnia","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120718_bib77","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/CIRCULATIONAHA.125.077665","article-title":"Low-Dose colchicine attenuates clonal hematopoiesis in COLCOT","volume":"153","author":"Tardif","year":"2026","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaccao.2021.01.001","article-title":"Clonal hematopoiesis and JAK2V617F Mutations in patients with cardiovascular disease","volume":"3","author":"Yokokawa","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120718_bib79","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.2023022260","article-title":"Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk","volume":"143","author":"Liu","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib85","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/ATVBAHA.123.320183","article-title":"Nonpreferential but detrimental accumulation of macrophages with clonal hematopoiesis-driver mutations in cardiovascular tissues-brief report","volume":"44","author":"Dederichs","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"436","key":"10.1016\/j.atherosclerosis.2026.120718_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120718_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171002","article-title":"Neutrophil-mediated innate immune resistance to bacterial pneumonia is dependent on Tet2 function","volume":"134","author":"Quin","year":"2024","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120718_bib88","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.stem.2023.05.004","article-title":"Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils","volume":"30","author":"Huerga Encabo","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"8098","key":"10.1016\/j.atherosclerosis.2026.120718_bib89","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41586-025-09807-0","article-title":"Architecture of the neutrophil compartment","volume":"649","author":"Cerezo-Wallis","year":"2026","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120718_bib90","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41375-018-0047-7","article-title":"Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis","volume":"32","author":"Arends","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib91","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120718_bib92","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ng.2966","article-title":"Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer","volume":"46","author":"Forsberg","year":"2014","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120718_bib93","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1007\/s00018-021-03822-w","article-title":"Immune cells lacking Y chromosome show dysregulation of autosomal gene expression","volume":"78","author":"Dumanski","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"6217","key":"10.1016\/j.atherosclerosis.2026.120718_bib94","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.1262092","article-title":"Mutagenesis. Smoking is associated with mosaic loss of chromosome Y","volume":"347","author":"Dumanski","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120718_bib95","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ng.3545","article-title":"Mosaic loss of chromosome Y is associated with common variation near TCL1A","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib96","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41431-019-0533-z","article-title":"Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals","volume":"28","author":"Danielsson","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"7784","key":"10.1016\/j.atherosclerosis.2026.120718_bib97","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41586-019-1765-3","article-title":"Genetic predisposition to mosaic Y chromosome loss in blood","volume":"575","author":"Thompson","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120718_bib98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ajhg.2024.12.014","article-title":"Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood","volume":"112","author":"Jakubek","year":"2025","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120718_bib99","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ajhg.2016.05.014","article-title":"Mosaic loss of chromosome Y in blood is associated with alzheimer disease","volume":"98","author":"Dumanski","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30759-1","article-title":"Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank","volume":"8","author":"Loftfield","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib101","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/0008-5472.CAN-18-2566","article-title":"Mosaic Y loss is moderately associated with solid tumor risk","volume":"79","author":"Loftfield","year":"2019","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146264","article-title":"Loss of Y chromosome in peripheral blood of colorectal and prostate cancer patients","volume":"11","author":"Noveski","year":"2016","journal-title":"PLoS One"},{"issue":"6603","key":"10.1016\/j.atherosclerosis.2026.120718_bib103","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.abn3100","article-title":"Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality","volume":"377","author":"Sano","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib104","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13059-024-03173-2","article-title":"Mosaic loss of Y chromosome is associated with aging and epithelial injury in chronic kidney disease","volume":"25","author":"Wilson","year":"2024","journal-title":"Genome Biol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120718_bib105","first-page":"1795","article-title":"Mosaic loss of Chromosome Y in aged human microglia","volume":"32","author":"Vermeulen","year":"2022","journal-title":"Genome Res"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.06.006","article-title":"Loss of chromosome Y in primary tumors","author":"Qi","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00428-008-0661-2","article-title":"End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue","volume":"453","author":"Hes","year":"2008","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120718_bib108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.21037\/atm-20-3061","article-title":"Y-chromosome loss is frequent in male renal tumors","volume":"9","author":"Buscheck","year":"2021","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120718_bib109","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0165-4608(95)00035-6","article-title":"Chromosomal abnormalities in non-neoplastic renal tissue","volume":"85","author":"van den Berg","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"issue":"7970","key":"10.1016\/j.atherosclerosis.2026.120718_bib110","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-023-06234-x","article-title":"Y chromosome loss in cancer drives growth by evasion of adaptive immunity","volume":"619","author":"Abdel-Hafiz","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120718_bib111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-4608(95)00030-S","article-title":"Y chromosome loss detected by FISH in bladder cancer","volume":"82","author":"Sauter","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib112","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.csbj.2023.02.024","article-title":"Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome","volume":"21","author":"Muller","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib113","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11357-024-01468-7","article-title":"A complex systems approach to mosaic loss of the Y chromosome","volume":"47","author":"Guo","year":"2025","journal-title":"GeroScience"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120718_bib114","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41588-023-01490-z","article-title":"Mutation rates and fitness consequences of mosaic chromosomal alterations in blood","volume":"55","author":"Watson","year":"2023","journal-title":"Nat Genet"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120718_bib115","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/eurheartj\/ehaf035","article-title":"Mosaic loss of Y chromosome and mortality after coronary angiography","volume":"46","author":"Weyrich","year":"2025","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib116","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2025.10.069","article-title":"Loss of Y chromosome and major cardiovascular events in a prospective study of older men","volume":"87","author":"Hussain","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib117","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.96150.3","article-title":"Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: an analysis in prospective studies","volume":"13","author":"Fawaz","year":"2024","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120718_bib118","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001544","article-title":"Loss of Y chromosome in blood is associated with major cardiovascular events during Follow-Up in men after carotid endarterectomy","volume":"10","author":"Haitjema","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120718_bib119","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-021-24504-y","article-title":"GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic health","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120718_bib120","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ng.3821","article-title":"Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility","volume":"49","author":"Wright","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2026.120718_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2019.113655","article-title":"Polycyclic aromatic hydrocarbons exposure and their joint effects with age, smoking, and TCL1A variants on mosaic loss of chromosome Y among coke-oven workers","volume":"258","author":"Liu","year":"2020","journal-title":"Environ Pollut"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:31:26Z","timestamp":1785893486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":121,"alternative-id":["S0021915026000845"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120718","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic somatic mutations in atherosclerotic cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120718"}}